Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
AbbVie
ABBV
|
+$239M |
| 2 |
Otis Worldwide
OTIS
|
+$156M |
| 3 |
Verizon
VZ
|
+$145M |
| 4 |
Baidu
BIDU
|
+$139M |
| 5 |
Carrier Global
CARR
|
+$135M |
Top Sells
| 1 |
Apple
AAPL
|
+$381M |
| 2 |
Amazon
AMZN
|
+$358M |
| 3 |
Bank of America
BAC
|
+$265M |
| 4 |
AGN
Allergan plc
AGN
|
+$259M |
| 5 |
Wells Fargo
WFC
|
+$241M |
Sector Composition
| 1 | Technology | 16.42% |
| 2 | Financials | 16.29% |
| 3 | Industrials | 12.58% |
| 4 | Healthcare | 11.61% |
| 5 | Consumer Discretionary | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Crane NXT
CXT
$3.56B
| $42.2M | 0.02% |
2,045,095
+89,436
| +5% | +$1.85M |
|
1352
NeoGenomics
NEO
$1.08B
| $42.2M | 0.02% |
1,363,360
-207,318
| -13% | -$6.42M |
|
|
BBT
1353
Beacon Financial Corporation
BBT
$2.2B
| $42.2M | 0.02% |
3,831,734
-250,146
| -6% | -$2.76M |
|
1354
Malibu Boats
MBUU
$652M
| $42.1M | 0.02% |
810,725
+30,114
| +4% | +$1.56M |
|
1355
Southside Bancshares
SBSI
$927M
| $42M | 0.02% |
1,516,325
-55,982
| -4% | -$1.55M |
|
1356
National Health Investors
NHI
$3.76B
| $41.9M | 0.02% |
690,451
+7,587
| +1% | +$461K |
|
1357
Bio-Techne
TECH
$8.28B
| $41.8M | 0.02% |
634,012
-70,052
| -10% | -$4.62M |
|
1358
OneSpan
OSPN
$591M
| $41.7M | 0.02% |
1,491,317
-61,753
| -4% | -$1.72M |
|
|
FARO
1359
DELISTED
Faro Technologies
FARO
| $41.5M | 0.02% |
775,146
-76,319
| -9% | -$4.09M |
|
1360
EPR Properties
EPR
$4.31B
| $41.5M | 0.02% |
1,253,727
+34,063
| +3% | +$1.13M |
|
1361
Radian Group
RDN
$4.81B
| $41.5M | 0.02% |
2,676,040
-21,545
| -0.8% | -$334K |
|
|
AEGN
1362
DELISTED
Aegion Corp
AEGN
| $41.5M | 0.02% |
2,614,855
-48,893
| -2% | -$776K |
|
1363
Mercer International
MERC
$209M
| $41.5M | 0.02% |
5,084,171
+84,537
| +2% | +$690K |
|
1364
Universal Electronics
UEIC
$64M
| $41.4M | 0.02% |
884,922
-6,707
| -0.8% | -$314K |
|
1365
Tredegar Corp
TG
$278M
| $41.4M | 0.02% |
2,688,725
+8,410
| +0.3% | +$130K |
|
1366
Amphastar Pharmaceuticals
AMPH
$1.33B
| $41.4M | 0.02% |
1,842,822
-4,531
| -0.2% | -$102K |
|
1367
Integra LifeSciences
IART
$1.21B
| $41.2M | 0.02% |
877,760
+32,403
| +4% | +$1.52M |
|
1368
Paylocity
PCTY
$9.48B
| $41.2M | 0.02% |
282,696
-111,924
| -28% | -$16.3M |
|
1369
Banc of California
BANC
$2.65B
| $41.2M | 0.02% |
3,804,424
-26,988
| -0.7% | -$292K |
|
1370
Capri Holdings
CPRI
$2.6B
| $41.1M | 0.02% |
2,631,289
-8,473
| -0.3% | -$132K |
|
|
IAA
1371
DELISTED
IAA, Inc. Common Stock
IAA
| $41.1M | 0.02% |
1,065,629
-47,539
| -4% | -$1.83M |
|
|
ITCI
1372
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $41.1M | 0.02% |
1,599,493
-35,489
| -2% | -$911K |
|
1373
Allete
ALE
$3.68B
| $41M | 0.02% |
750,599
-24,501
| -3% | -$1.34M |
|
1374
Incyte
INCY
$16.8B
| $40.9M | 0.02% |
393,659
-11,333
| -3% | -$1.18M |
|
|
SJI
1375
DELISTED
South Jersey Industries, Inc.
SJI
| $40.9M | 0.02% |
1,634,849
-94,458
| -5% | -$2.36M |
|